Shanghai-Hong Kong Zhongke
Biopharmaceutical preclinical research and development service company
Company News
Company News
2023-06-01
Empowering Original Innovation | Key Factors in Early Drug-like Properties Evaluation of Chemical Compounds -ZSHK & MacauUWith the strengthening of Chinas economic and technological capabilities, the research and development of new drugs will inevitably aim for higher goals, achieving a new historical transformation. This transition will progress from imitative...
Read more +2023-05-19
ZSHK attended the 3rd Asia Medical and Health SummitMay 17, 2023, Hong Kong, China. The 3rd Asia Medical and Health Summit (ASGH), jointly organized by the Hong Kong Special Administrative Region Government and the Hong Kong Trade Development Council, was grandly held at the Hong Kong Convent...
Read more +2023-05-05
Good news! Anling Biomed (Shenzhen) Co. Ltd. has successfully passed the GLP certification issued by the National Medical Products Administration.Good news! Anling (Shenzhen) has successfully passed the GLP certification issued by NMPA Recently, Anling Biomed(Shenzhen) Co., Ltd., a wholly-owned subsidiary of ZSHK LaboratoriesLimited(ZSHK), received a GLP certificate (registration ...
Read more +2023-04-24
ZSHK successfully hosted a reception banquet.On the evening of February 28th, 2023, on the banks of the fragrant harbor, with a gentle breeze blowing, to welcome and celebrate the visit of the China Pharmaceutical Innovation and Research Development Association (PhIRDA) delegation to H...
Read more +2023-02-16
Great News|Anling Biomed (Suzhou) Successfully Gains Extending GLP Accreditation from NMPARecently, Anling Biomed (Suzhou)Co., Ltd (Anling (Suzhou))wholly-owned subsidiaries of ZSHK Laboratories Limited (ZSHK) has been awarded GLP accreditation (Registration Number:GLP23002157) issued by the National Medical Products Administrati...
Read more +